Order Article Reprints

Tanabe N, Saeki I, Aibe Y, Matsuda T, Hanazono T, Nishi M, Hidaka I, Kuwashiro S, Shiratsuki S, Matsuura K, et al. Early Prediction of Response Focused on Tumor Markers in Atezolizumab plus Bevacizumab Therapy for Hepatocellular Carcinoma. Cancers. 2023; 15(11):2927. https://doi.org/10.3390/cancers15112927

Tanabe, Norikazu, Issei Saeki, Yuki Aibe, Takashi Matsuda, Tadasuke Hanazono, Maiko Nishi, Isao Hidaka, Shinya Kuwashiro, Shogo Shiratsuki, Keiji Matsuura, and et al. 2023. "Early Prediction of Response Focused on Tumor Markers in Atezolizumab plus Bevacizumab Therapy for Hepatocellular Carcinoma" Cancers 15, no. 11: 2927. https://doi.org/10.3390/cancers15112927

Tanabe, N., Saeki, I., Aibe, Y., Matsuda, T., Hanazono, T., Nishi, M., Hidaka, I., Kuwashiro, S., Shiratsuki, S., Matsuura, K., Egusa, M., Nishiyama, N., Fujioka, T., Kawamoto, D., Sasaki, R., Nishimura, T., Oono, T., Hisanaga, T., Matsumoto, T., ... Takami, T. (2023). Early Prediction of Response Focused on Tumor Markers in Atezolizumab plus Bevacizumab Therapy for Hepatocellular Carcinoma. Cancers, 15(11), 2927. https://doi.org/10.3390/cancers15112927